Published in Circulation on February 02, 2004
Reactive oxygen species in cardiovascular disease. Free Radic Biol Med (2011) 2.29
Oxidative risk for atherothrombotic cardiovascular disease. Free Radic Biol Med (2009) 1.24
Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study. Cardiovasc Diabetol (2015) 1.17
Biomarkers of obesity and subsequent cardiovascular events. Epidemiol Rev (2007) 1.17
Redox signaling in cardiovascular health and disease. Free Radic Biol Med (2013) 1.16
Endothelial function and aminothiol biomarkers of oxidative stress in healthy adults. Hypertension (2008) 1.15
Evaluating oxidative stress in human cardiovascular disease: methodological aspects and considerations. Curr Med Chem (2012) 1.15
F2-isoprostanes as an indicator and risk factor for coronary heart disease. Free Radic Biol Med (2010) 1.04
Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis. Arthritis Care Res (Hoboken) (2010) 1.02
Cardiovascular consequences when nitric oxide and lipid signaling converge. Circ Res (2009) 0.98
Emerging risk factors for cardiovascular diseases: Indian context. Indian J Endocrinol Metab (2013) 0.97
Fluorescent oxidation products and risk of coronary heart disease: a prospective study in women. J Am Heart Assoc (2013) 0.94
Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study. Atherosclerosis (2013) 0.92
Obesity, age, and oxidative stress in middle-aged and older women. Antioxid Redox Signal (2011) 0.92
Long-term effect of mediterranean-style diet and calorie restriction on biomarkers of longevity and oxidative stress in overweight men. Cardiol Res Pract (2010) 0.90
Increased plasma isoprostane is associated with visceral fat, high molecular weight adiponectin, and metabolic complications in obese children. Eur J Pediatr (2010) 0.89
Diet-gene interactions and PUFA metabolism: a potential contributor to health disparities and human diseases. Nutrients (2014) 0.89
Skin autofluorescence is elevated in acute myocardial infarction and is associated with the one-year incidence of major adverse cardiac events. Neth Heart J (2009) 0.89
Relationship between a common variant in the fatty acid desaturase (FADS) cluster and eicosanoid generation in humans. J Biol Chem (2014) 0.89
Interactions between the APOA5 -1131T>C and the FEN1 10154G>T polymorphisms on ω6 polyunsaturated fatty acids in serum phospholipids and coronary artery disease. J Lipid Res (2010) 0.87
Selective gamma-ketoaldehyde scavengers protect Nav1.5 from oxidant-induced inactivation. J Mol Cell Cardiol (2009) 0.87
Fatty Acid Oxidation and Cardiovascular Risk during Menopause: A Mitochondrial Connection? J Lipids (2012) 0.85
The relationship of oxidative stress, adiposity and metabolic risk factors in healthy Black and White American youth. Pediatr Obes (2013) 0.84
Lipid peroxidation and depressed mood in community-dwelling older men and women. PLoS One (2013) 0.83
Oxidative stress and response in relation to coronary artery disease in type 1 diabetes. Diabetes Care (2013) 0.83
Measurement of Reactive Oxygen Species, Reactive Nitrogen Species, and Redox-Dependent Signaling in the Cardiovascular System: A Scientific Statement From the American Heart Association. Circ Res (2016) 0.83
Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation. Br J Pharmacol (2014) 0.82
Chitin-glucan fiber effects on oxidized low-density lipoprotein: a randomized controlled trial. Eur J Clin Nutr (2012) 0.82
Atherosclerotic cardiovascular disease: a review of initiators and protective factors. Inflammopharmacology (2016) 0.81
Association of polymorphisms in FADS gene with age-related changes in serum phospholipid polyunsaturated fatty acids and oxidative stress markers in middle-aged nonobese men. Clin Interv Aging (2013) 0.81
Analysis of F2-isoprostanes in plasma of pregnant women by HPLC-MS/MS using a column packed with core-shell particles. J Lipid Res (2013) 0.81
Fatty acid desaturase 1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaque. Diabetes Metab Syndr Obes (2016) 0.80
3-nitrotyrosine modified proteins in atherosclerosis. Dis Markers (2015) 0.80
Impact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients. Br J Clin Pharmacol (2007) 0.80
Sex differences in urinary biomarkers of vascular and endothelial function in HIV-infected persons receiving antiretroviral therapy. Antivir Ther (2011) 0.79
LC-MS/MS Determination of Isoprostanes in Plasma Samples Collected from Mice Exposed to Doxorubicin or Tert-Butyl Hydroperoxide. Int J Mol Sci (2013) 0.79
Oxidative status and cardiovascular risk in women: Keeping pink at heart. World J Cardiol (2009) 0.79
"Old" hearts and arteries: the role of oxidative stress. Trans Am Clin Climatol Assoc (2010) 0.79
Classifying oxidative stress by F2-isoprostane levels across human diseases: A meta-analysis. Redox Biol (2017) 0.79
A urinary marker of oxidative stress covaries positively with hostility among midlife community volunteers. Psychosom Med (2010) 0.78
F2-isoprostanes are correlated with trans fatty acids in the plasma of pregnant women. Prostaglandins Leukot Essent Fatty Acids (2014) 0.78
Urinary eicosanoid metabolites in HIV-infected women with central obesity switching to raltegravir: an analysis from the women, integrase, and fat accumulation trial. Mediators Inflamm (2014) 0.78
Effective Components of Panax quinquefolius and Corydalis tuber Protect Myocardium through Attenuating Oxidative Stress and Endoplasmic Reticulum Stress. Evid Based Complement Alternat Med (2013) 0.78
MnSOD and GPx1 polymorphism relationship with coronary heart disease risk and severity. Biol Res (2016) 0.77
Oxidative stress, inflammation, and muscle soreness in an 894-km relay trail run. Eur J Appl Physiol (2011) 0.77
Improved method of plasma 8-Isoprostane measurement and association analyses with habitual drinking and smoking. World J Gastroenterol (2006) 0.77
Urinary levels of 8-iso-prostaglandin f2α and 8-hydroxydeoxyguanine as markers of oxidative stress in patients with coronary artery disease. Korean Circ J (2012) 0.77
Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery disease. World J Diabetes (2014) 0.76
Antioxidants and coronary artery disease: from pathophysiology to preventive therapy. Coron Artery Dis (2015) 0.76
Development of nonfibrotic left ventricular hypertrophy in an ANG II-induced chronic ovine hypertension model. Physiol Rep (2016) 0.76
Plaque regression in one artery is not necessarily associated with parallel changes in other vascular beds. Heart Vessels (2010) 0.76
Paraoxonase-1 and Simvastatin Treatment in Patients with Stable Coronary Artery Disease. Int J Vasc Med (2016) 0.75
Physicochemistry and cardiovascular toxicity of metal fume PM2.5: a study of human coronary artery endothelial cells and welding workers. Sci Rep (2016) 0.75
A comparative study of time-specific oxidative stress after acute myocardial infarction in patients with and without diabetes mellitus. BMC Cardiovasc Disord (2016) 0.75
Longitudinal Impact of Smoking and Smoking Cessation on Inflammatory Markers of Cardiovascular Disease Risk. Arterioscler Thromb Vasc Biol (2016) 0.75
8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease. Circulation (2004) 0.75
Urine Eicosanoids in the Metabolic Abnormalities, Telmisartan, and HIV Infection (MATH) Trial. PLoS One (2017) 0.75
The association of serum trans-nonachlor levels with atherosclerosis. J Toxicol Environ Health A (2016) 0.75
Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest (2002) 6.35
The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke (2003) 4.63
Helicobacter exploits integrin for type IV secretion and kinase activation. Nature (2007) 4.02
Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol (2008) 3.91
Clinical and angiographic risk factors for stroke and death within 30 days after carotid endarterectomy and stent-protected angioplasty: a subanalysis of the SPACE study. Lancet Neurol (2008) 2.53
Control of crystal size and lattice formation by starmaker in otolith biomineralization. Science (2003) 2.35
Effects of multiple deletions of murein hydrolases on viability, septum cleavage, and sensitivity to large toxic molecules in Escherichia coli. J Bacteriol (2002) 2.29
Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes (2007) 2.12
Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation (2003) 2.12
Adverse drug events in older patients admitted as an emergency: the role of potentially inappropriate medication in elderly people (PRISCUS). Dtsch Arztebl Int (2013) 2.06
Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation (2009) 2.05
Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy. Int J Cancer (2008) 2.01
Serum response factor is crucial for actin cytoskeletal organization and focal adhesion assembly in embryonic stem cells. J Cell Biol (2002) 1.99
Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol (2005) 1.99
Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation (2002) 1.93
Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc Natl Acad Sci U S A (2004) 1.87
Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet (2003) 1.84
ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins. Cardiovasc Res (2003) 1.78
Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significance. J Clin Oncol (2002) 1.75
Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*. J Hypertens (2006) 1.74
Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179. Circ Res (2002) 1.71
Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol (2002) 1.70
Chest radiography for the diagnosis of acute aortic syndrome. Am J Med (2004) 1.68
Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells. Cardiovasc Res (2006) 1.65
Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects. Circulation (2003) 1.63
Tissue Doppler imaging identifies myocardial dysfunction in adults with Marfan syndrome. Clin Cardiol (2007) 1.63
Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ Res (2007) 1.61
Oxidative stress and human diseases: Origin, link, measurement, mechanisms, and biomarkers. Crit Rev Clin Lab Sci (2009) 1.60
Augmentation index relates to progression of aortic disease in adults with Marfan syndrome. Am J Hypertens (2009) 1.60
Specific entry of Helicobacter pylori into cultured gastric epithelial cells via a zipper-like mechanism. Infect Immun (2002) 1.59
The role of asymmetric and symmetric dimethylarginines in renal disease. Nat Rev Nephrol (2011) 1.58
Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial. Eur Heart J (2004) 1.58
Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. Br J Clin Pharmacol (2007) 1.53
Predictors of aneurysmal formation after surgical correction of aortic coarctation. J Am Coll Cardiol (2002) 1.51
Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes. BJU Int (2012) 1.50
Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. J Clin Oncol (2003) 1.49
Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med (2010) 1.49
Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension. Chest (2012) 1.48
Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort. Stroke (2009) 1.47
A retrospective comparison of costs for regional and general anesthesia techniques. Anesth Analg (2005) 1.42
Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin Chem Lab Med (2004) 1.41
Quantification of arginine and its mono- and dimethylated analogs NMMA, ADMA and SDMA in biological fluids by LC-MS/MS: Is LC superfluous? J Chromatogr B Analyt Technol Biomed Life Sci (2009) 1.39
[Medication errors. Cause of death for every 100th hospital patient? (interview by Dr. Thomas Meissner)]. MMW Fortschr Med (2003) 1.39
Assessment of nitric oxide biosynthesis and peroxynitrite formation within the central nervous system by measuring L-citrulline in the cerebrospinal fluid? J Chromatogr B Analyt Technol Biomed Life Sci (2004) 1.38
Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma. Eur J Cancer (2002) 1.38
Nitric oxide synthesis in chronic renal failure. Are plasma S-nitrosothiol levels elevated? Clin Chim Acta (2004) 1.38
Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases. BMJ (2003) 1.37
Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice. Stroke (2004) 1.37
Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol (2005) 1.33
Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality--an update on patient populations with a wide range of cardiovascular risk. Pharmacol Res (2009) 1.31
Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells. Clin Cancer Res (2004) 1.31
High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 1.30
Intramural hematoma of the aorta: predictors of progression to dissection and rupture. Circulation (2003) 1.30
Liquid chromatography-tandem mass spectrometry method for the analysis of asymmetric dimethylarginine in human plasma. Clin Chem (2005) 1.26
CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease. J Clin Oncol (2002) 1.21
Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients. Kidney Int (2002) 1.20
Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine. Arterioscler Thromb Vasc Biol (2011) 1.19
Oral L-arginine improves endothelial function in healthy individuals older than 70 years. Vasc Med (2003) 1.19
Cuticle differentiation during Drosophila embryogenesis. Arthropod Struct Dev (2006) 1.17
Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J Am Soc Nephrol (2002) 1.17
Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free Radic Biol Med (2004) 1.16
Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease. Free Radic Biol Med (2005) 1.15
The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function. Vasc Med (2002) 1.15
Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: a key role for ubiquitin-conjugating enzymes. Eur Heart J (2010) 1.14
A nuclear actin function regulates neuronal motility by serum response factor-dependent gene transcription. J Neurosci (2009) 1.13
Differences in complication rates among the centres in the SPACE study. Neuroradiology (2008) 1.13
Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress. Clin Pharmacokinet (2003) 1.12
Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease. J Am Coll Cardiol (2004) 1.12
Application of gas chromatography-mass spectrometry for analysis of isoprostanes: their role in cardiovascular disease. Clin Chem Lab Med (2003) 1.11
Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? Hypertension (2013) 1.11
Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine. Circulation (2009) 1.10
Can nitric oxide synthase activity be unequivocally measured in red Blood cells and platelets? if yes, by which assay? Redox Biol (2015) 1.08
Comparative evaluation of urokinase-type plasminogen activator receptor expression in primary breast carcinomas and on metastatic tumor cells. Int J Cancer (2003) 1.08
CEACAM1 enhances invasion and migration of melanocytic and melanoma cells. Am J Pathol (2004) 1.08
Role of asymmetric dimethylarginine for angiotensin II-induced target organ damage in mice. Am J Physiol Heart Circ Physiol (2007) 1.07
Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke. Atherosclerosis (2009) 1.07